Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
Multiple sclerosis guideline production takes off.
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis.
Onset of neuromyelitis optica in the elderly.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
A proposed roadmap for inpatient neurology quality indicators.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
A program to facilitate retention of employment among persons with multiple sclerosis.
Callosal anatomical and effective connectivity between primary motor cortices predicts visually cued bimanual temporal coordination performance.
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »